Erectile Dysfunction Completed Phase 2 Trials for Udenafil (DB06267)

Also known as: ED / Erectile difficulties / Erectile Dysfunction (ED) / Difficulty maintaining an erection / Decreased erections / Male Erectile Disorder / Male Erectile Dysfunction / Difficult erection / Inability to achieve or maintain erection / Erectile Dysfunctions / Erectile disorder / Erectile dysfunction (disorder) / Male erectile disorder (disorder) / Impotence (disorder) / Impotence / (Frigidity or impotence) or (lack or loss of libido) or (psychogen.dyspareunia) or (fear of ejaculation) or (premature ejaculation) / Erectile dysfunction NOS / Sexual impotence (finding) / [X] Failure of genital response (& [female sexual arousal disorder] or [male erectile disorder] or [psychogenic impotence]) / Impotent / Erectile disturbance / Erection failure / Psychogenic impotence / Psychogenic impotence (finding)

IndicationStatusPhase
DBCOND0029956 (Erectile Dysfunction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00282607A Study of DA-8159 in Subjects With Erectile DysfunctionTreatment
NCT00607282Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal CancerTreatment